{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:27:49Z","timestamp":1793946469465,"version":"4.8.0"},"reference-count":228,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803895"],"award-info":[{"award-number":["81803895"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021YQ57"],"award-info":[{"award-number":["ZR2021YQ57"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024MH266"],"award-info":[{"award-number":["ZR2024MH266"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.117961","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:47:19Z","timestamp":1776282439000},"page":"117961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Ubiquitin-specific peptidase 51: A potential target in cancer progression and therapy"],"prefix":"10.1016","volume":"250","author":[{"given":"Lifan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6429-6749","authenticated-orcid":false,"given":"Lina","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.117961_b0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nrm.2017.22","article-title":"Protein O-GlcNAcylation: emerging mechanisms and functions","volume":"18","author":"Yang","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41467-023-35795-8","article-title":"Control of protein stability by post-translational modifications","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117961_b0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","article-title":"Ubiquitination in the regulation of inflammatory cell death and cancer","volume":"28","author":"Cockram","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.117961_b0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","article-title":"The role of ubiquitination and deubiquitination in cancer metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.117961_b0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.bcp.2026.117961_b0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1476-4598-12-91","article-title":"USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy","volume":"12","author":"Garc\u00eda-Santisteban","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.117961_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101077","article-title":"Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response","volume":"297","author":"Snyder","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.117961_b0040","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.trecan.2019.08.005","volume":"5","author":"Mennerich","year":"2019","journal-title":"And Cancer, Trends in Cancer"},{"key":"10.1016\/j.bcp.2026.117961_b0045","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.molcel.2013.01.017","article-title":"Regulation of DNA damage responses by ubiquitin and SUMO","volume":"49","author":"Jackson","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0050","first-page":"2784","article-title":"FAT4-USP51 complex regulates the proliferation and invasion of endometrial cancer via Hippo pathway","volume":"11","author":"Che","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bcp.2026.117961_b0055","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cac2.12460","article-title":"USP51\/PD-L1\/ITGB1-deployed juxtacrine interaction plays a cell-intrinsic role in promoting chemoresistant phenotypes in non-small cell lung cancer","volume":"43","author":"Li","year":"2023","journal-title":"Cancer Communications (london, England)"},{"key":"10.1016\/j.bcp.2026.117961_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41392-020-0118-x","article-title":"CDK4\/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0065","doi-asserted-by":"crossref","first-page":"31802","DOI":"10.1038\/s41598-025-17310-9","article-title":"Regulation of divergent epithelial-to-mesenchymal transition responses via the CDK4\/6-USP51 pathway through ZEB1 protein stabilization","volume":"15","author":"Sakamoto","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117961_b0070","first-page":"717","article-title":"USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination","volume":"46","author":"Zhao","year":"2023","journal-title":"Cellular Oncology (dordrecht, Netherlands)"},{"key":"10.1016\/j.bcp.2026.117961_b0075","volume":"10","author":"Guan","year":"2023"},{"key":"10.1016\/j.bcp.2026.117961_b0080","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/mc.23593","article-title":"USP12 promotes nonsmall cell lung cancer progression through deubiquitinating and stabilizing RRM2","volume":"62","author":"Chen","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2026.117961_b0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12967-023-04304-2","article-title":"USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.117961_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106644","article-title":"USP51\/ZEB1\/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics","volume":"188","author":"Liu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.117961_b0095","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.apsb.2025.03.004","article-title":"USP51\/GRP78\/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells","volume":"15","author":"Ou","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.117961_b0100","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ (clinical Research Ed.)"},{"key":"10.1016\/j.bcp.2026.117961_b0105","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline, Journal of clinical oncology : official journal of the","volume":"39","author":"Korde","year":"2021","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.117961_b0110","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.apsb.2024.03.012","article-title":"Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer","volume":"14","author":"Gao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.117961_b0115","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/s41418-023-01228-8","article-title":"USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A","volume":"30","author":"Mu","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.117961_b0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","article-title":"Mechanisms of Deubiquitinase Specificity and Regulation","volume":"86","author":"Mevissen","year":"2017","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.bcp.2026.117961_b0125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/embor.2011.17","article-title":"Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21","volume":"12","author":"Ye","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcp.2026.117961_b0130","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41589-024-01777-0","article-title":"Discovery and mechanism of K63-linkage-directed deubiquitinase activity in USP53","volume":"21","author":"Wendrich","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0135","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0092-8674(02)01199-6","article-title":"Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde","volume":"111","author":"Hu","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0140","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1039\/B907669G","article-title":"Dissection of USP catalytic domains reveals five common insertion points","volume":"5","author":"Ye","year":"2009","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.bcp.2026.117961_b0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-019-0522-0","article-title":"The role of ubiquitin-specific peptidases in cancer progression","volume":"26","author":"Young","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b0150","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s10495-025-02095-z","article-title":"Role of the USP family in autophagy regulation and cancer progression","volume":"30","author":"Liu","year":"2025","journal-title":"Apoptosis : an International Journal on Programmed Cell Death"},{"key":"10.1016\/j.bcp.2026.117961_b0155","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180250","article-title":"USP18 - a multifunctional component in the interferon response","volume":"38","author":"Basters","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bcp.2026.117961_b0160","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41420-023-01629-1","article-title":"USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.bcp.2026.117961_b0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-024-02005-y","article-title":"Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-specific Proteases (USPs) in cancers: new directions and therapeutic options","volume":"23","author":"Gao","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.117961_b0170","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/pro.3675","article-title":"Structural and functional studies of USP20 ZnF-UBP domain by NMR","volume":"28","author":"Yang","year":"2019","journal-title":"Protein Science : a Publication of the Protein Society"},{"key":"10.1016\/j.bcp.2026.117961_b0175","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.cell.2006.02.038","article-title":"The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin","volume":"124","author":"Reyes-Turcu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0180","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/bi200854q","article-title":"Two ZnF-UBP domains in isopeptidase T","volume":"51","author":"Avvakumov","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2026.117961_b0185","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1042\/CBI20090144","article-title":"K48- and K63-linked polyubiquitination of deubiquitinating enzyme USP44","volume":"34","author":"Suresh","year":"2010","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bcp.2026.117961_b0190","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1110\/ps.072967807","article-title":"The solution structure of the ZnF UBP domain of USP33\/VDU1","volume":"16","author":"Allen","year":"2007","journal-title":"Protein Science : a Publication of the Protein Society"},{"key":"10.1016\/j.bcp.2026.117961_b0195","unstructured":"Summary and Model Confidence of Ubiquitin carboxyl-terminal hydrolase 51, AlphaFold Protein Structure Database Available online: https:\/\/alphafold.ebi.ac.uk\/entry\/AF-Q70EK9-F1, (accessed on 11 February 2026)."},{"key":"10.1016\/j.bcp.2026.117961_b0200","unstructured":"Q70EK9 \u00b7 UBP51_HUMAN, UniProt Knowledgebase (UniProtKB) online: https:\/\/www.uniprot.org\/uniprotkb\/Q70EK9\/entry, (accessed on 10 March 2026)."},{"key":"10.1016\/j.bcp.2026.117961_b0205","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1038\/sj.emboj.7600832","article-title":"Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14","volume":"24","author":"Hu","year":"2005","journal-title":"EMBO J."},{"issue":"2006","key":"10.1016\/j.bcp.2026.117961_b0210","first-page":"1293","article-title":"Structural basis of ubiquitin recognition by the deubiquitinating protease USP2, Structure (London","volume":"14","author":"Renatus","year":"1993","journal-title":"England"},{"key":"10.1016\/j.bcp.2026.117961_b0215","doi-asserted-by":"crossref","first-page":"38061","DOI":"10.1074\/jbc.M606704200","article-title":"Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8","volume":"281","author":"Avvakumov","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.117961_b0220","doi-asserted-by":"crossref","unstructured":"G.J. Valles, E.J. Korchak, D.H. Geddes-Buehre, N. Jaiswal, D.M. Korzhnev, I. Bezsonova, Activation dynamics of ubiquitin-specific protease 7, Proceedings of the National Academy of Sciences of the United States of America, 122 (2025) e2426632122.","DOI":"10.1073\/pnas.2426632122"},{"key":"10.1016\/j.bcp.2026.117961_b0225","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70077","article-title":"Dynamic networks connect the USP14 active site region with the proteasome interaction surface","volume":"34","author":"Salomonsson","year":"2025","journal-title":"Protein Science : a Publication of the Protein Society"},{"key":"10.1016\/j.bcp.2026.117961_b0230","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1073\/pnas.1815027116","article-title":"Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X","volume":"116","author":"Paudel","year":"2019","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.117961_b0235","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14799","article-title":"Ubiquitin specific peptidases and prostate cancer","volume":"11","author":"Guo","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.bcp.2026.117961_b0240","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","article-title":"A genomic and functional inventory of deubiquitinating enzymes","volume":"123","author":"Nijman","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147746","article-title":"Expression and Role of Ubiquitin-specific Peptidases in Osteoblasts","volume":"22","author":"Hariri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b0250","article-title":"Advances in the Development Ubiquitin-specific Peptidase (USP) Inhibitors","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b0255","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0260","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/cr.2016.38","article-title":"Substrate specificity of the ubiquitin and Ubl proteases","volume":"26","author":"Ronau","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2026.117961_b0265","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1101\/gad.271841.115","article-title":"USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response","volume":"30","author":"Wang","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2026.117961_b0270","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm2351","article-title":"Regulation of DNA repair throughout the cell cycle","volume":"9","author":"Branzei","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0275","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.117961_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216594","article-title":"Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma","volume":"582","author":"Hong","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.117961_b0285","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-025-02291-0","article-title":"DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer","volume":"24","author":"Morris","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.117961_b0290","first-page":"3874","article-title":"Targeting the DNA damage Response Pathways and Replication stress in Colorectal Cancer, Clinical cancer research : an official journal of the American Association for","volume":"28","author":"Durinikova","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117961_b0295","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cell.2007.09.041","article-title":"RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly","volume":"131","author":"Huen","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0300","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/nsmb.2702","article-title":"JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1-mediated chromatin response to DNA breaks","volume":"20","author":"Watanabe","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0305","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1083\/jcb.200902150","article-title":"Nucleotide excision repair-induced H2A ubiquitination is dependent on MDC1 and RNF8 and reveals a universal DNA damage response","volume":"186","author":"Marteijn","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2021.103217","article-title":"The RNF8 and RNF168 Ubiquitin Ligases Regulate Pro- and Anti-Resection Activities at Broken DNA Ends during Non-Homologous End joining","volume":"108","author":"Chen","year":"2021","journal-title":"DNA Repair"},{"key":"10.1016\/j.bcp.2026.117961_b0315","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41418-025-01472-0","article-title":"ZNF451 collaborates with RNF8 to regulate RNF168 localization and amplify ubiquitination signaling to promote DNA damage repair and regulate radiosensitivity","volume":"32","author":"Xu","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.117961_b0320","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature15401","article-title":"Histone H1 couples initiation and amplification of ubiquitin signalling after DNA damage","volume":"527","author":"Thorslund","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.117961_b0325","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cell.2008.12.041","article-title":"RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins","volume":"136","author":"Doil","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0330","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.cell.2012.08.005","article-title":"RNF168 ubiquitinates K13-15 on H2A\/H2AX to drive DNA damage signaling","volume":"150","author":"Mattiroli","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0335","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12318","article-title":"53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark","volume":"499","author":"Fradet-Turcotte","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.117961_b0340","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2010.03.012","article-title":"53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks","volume":"141","author":"Bunting","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0345","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0350","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.117961_b0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0360","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0365","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.semcancer.2021.10.002","article-title":"Hypoxia signaling: challenges and opportunities for cancer therapy","volume":"85","author":"Ivan","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115703","article-title":"Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target","volume":"22","author":"Infantino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b0375","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.117961_b0380","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","article-title":"ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer","volume":"41","author":"Dong","year":"2022","journal-title":"Journal of Experimental & Clinical Cancer Research : CR"},{"key":"10.1016\/j.bcp.2026.117961_b0385","article-title":"HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2026.117961_b0390","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","article-title":"The Hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0395","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.stem.2024.03.003","article-title":"NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells invitro and invivo","volume":"31","author":"Namoto","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0400","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41419-024-06860-x","article-title":"The circadian gene ARNTL2 promotes nasopharyngeal carcinoma invasiveness and metastasis through suppressing AMOTL2-LATS-YAP pathway","volume":"15","author":"Zou","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117961_b0405","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41556-021-00813-8","article-title":"The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1","volume":"24","author":"Han","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0410","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12885-020-06900-7","article-title":"FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and \u03b2-catenin activity in ovarian cancer","volume":"20","author":"Malgundkar","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2026.117961_b0415","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/15384047.2015.1108488","article-title":"Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells","volume":"17","author":"Ma","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105723","article-title":"The novel FAT4 activator jujuboside a suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation","volume":"170","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.117961_b0425","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/mc.22335","article-title":"Twist1 regulates keratinocyte proliferation and skin tumor promotion","volume":"55","author":"Srivastava","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2026.117961_b0430","doi-asserted-by":"crossref","unstructured":"E.F. de Morais, H.G. de Farias Morais, E. de Moura Santos, C.A.G. Barboza, F.H. T\u00e9o, T. Salo, R.D. Coletta, R. de Almeida Freitas, TWIST1 regulates proliferation, migration, and invasion and is a prognostic marker for oral tongue squamous cell carcinoma, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 52 (2023) 127-135.","DOI":"10.1111\/jop.13377"},{"key":"10.1016\/j.bcp.2026.117961_b0435","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-24-0048","article-title":"FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination and degradation","volume":"32","author":"Zhao","year":"2025","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bcp.2026.117961_b0440","doi-asserted-by":"crossref","first-page":"225","DOI":"10.7150\/ijbs.75459","article-title":"HIF-1\u03b1\/YAP Signaling Rewrites Glucose\/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression","volume":"19","author":"Song","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b0445","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312868","article-title":"The Hippo Pathway in Breast Cancer: the Extracellular Matrix and Hypoxia","volume":"25","author":"Yang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b0450","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2016.09.027","article-title":"Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells invitro and in nude mice","volume":"383","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.117961_b0455","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/0115748928293750240619092747","article-title":"Epigallocatechin Gallate Derivative Y(6) Reverses Oxaliplatin Resistance in Hepatocellular Carcinoma via Targeting the MiR-338-3p\/HIF-1\u03b1\/TWIST Axis to Inhibit EMT","volume":"20","author":"Huang","year":"2025","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.bcp.2026.117961_b0460","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41419-020-2725-4","article-title":"Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117961_b0465","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0470","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","article-title":"Apoptosis in Cancer Biology and Therapy","volume":"20","author":"Moyer","year":"2025","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bcp.2026.117961_b0475","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/clr.14067","article-title":"Anti-Apoptotic and Pro-Apoptotic Bcl-2 Family Proteins in Peri-Implant Diseases","volume":"34","author":"Yilmaz","year":"2023","journal-title":"Clin. Oral Implant Res."},{"key":"10.1016\/j.bcp.2026.117961_b0480","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","article-title":"BCL-2 protein family: attractive targets for cancer therapy","volume":"28","author":"Kaloni","year":"2023","journal-title":"Apoptosis : an International Journal on Programmed Cell Death"},{"key":"10.1016\/j.bcp.2026.117961_b0485","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061292","article-title":"Targeting BCL-2 in Cancer: advances, challenges, and Perspectives","volume":"13","author":"Hafezi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.117961_b0490","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1038\/sj.onc.1204926","article-title":"Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer","volume":"20","author":"Catz","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117961_b0495","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/sj.onc.1204343","article-title":"Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines","volume":"20","author":"Bentires-Alj","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117961_b0500","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00262-011-1008-4","article-title":"Targeting the extrinsic apoptosis signaling pathway for cancer therapy","volume":"60","author":"Sayers","year":"2011","journal-title":"Cancer Immunology, Immunotherapy : CII"},{"key":"10.1016\/j.bcp.2026.117961_b0505","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5483\/BMBRep.2019.52.2.011","article-title":"E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway","volume":"52","author":"Woo","year":"2019","journal-title":"BMB Rep."},{"key":"10.1016\/j.bcp.2026.117961_b0510","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121960","article-title":"Hispidulin Enhances TRAIL-Mediated Apoptosis via CaMKK\/AMPK\/USP51 Axis-Mediated Bim Stabilization","volume":"11","author":"Woo","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.117961_b0515","doi-asserted-by":"crossref","unstructured":"Q. Liu, E.J. Osterlund, X. Chi, J. Pogmore, B. Leber, D.W. Andrews, Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2, eLife, 8 (2019).","DOI":"10.7554\/eLife.37689"},{"key":"10.1016\/j.bcp.2026.117961_b0520","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2026.117961_b0525","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0530","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220504","article-title":"GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection","volume":"219","author":"Amaral","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.117961_b0535","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-025-02296-7","article-title":"Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1\/2 and GPX4 in colorectal cancer","volume":"10","author":"Yu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0540","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0545","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117961_b0550","article-title":"Berbamine promotes ferroptosis of esophageal squamous cell carcinoma by facilitating USP51-mediated GPX4 ubiquitination and degradation","volume":"179","author":"Peng","year":"2024","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.bcp.2026.117961_b0555","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0560","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0565","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0570","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2192501","article-title":"YAP and \u03b2-catenin cooperate to drive H. pylori-induced gastric tumorigenesis","volume":"15","author":"Li","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bcp.2026.117961_b0575","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.117961_b0580","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.7150\/thno.56490","article-title":"ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM","volume":"11","author":"Zhou","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.117961_b0585","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1053\/j.gastro.2020.12.077","article-title":"Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal transition Plasticity and Metastasis in Pancreatic Cancer","volume":"160","author":"Liu","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2026.117961_b0590","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41419-022-04935-1","article-title":"Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1\u03b1\/ZEB1 axis","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117961_b0595","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1038\/sj.onc.1210508","article-title":"The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity","volume":"26","author":"Aigner","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117961_b0600","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1038\/s41467-025-63083-0","article-title":"STN1 facilitates metastasis by promoting transcription of EMT-activator ZEB1 in pancreatic cancer","volume":"16","author":"Dong","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117961_b0605","first-page":"2020","article-title":"USP51 promotes deubiquitination and stabilization of ZEB1","volume":"7","author":"Zhou","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117961_b0610","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41417-021-00420-7","article-title":"CDK4\/6-USP51 axis regulates lung adenocarcinoma metastasis through ZEB1","volume":"29","author":"Li","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0615","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/1878-0261.12948","article-title":"Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges","volume":"15","author":"Garcia-Pelaez","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2026.117961_b0620","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13091294","article-title":"YAP Activation is Associated with a worse Prognosis of Poorly Cohesive Gastric Cancer","volume":"13","author":"Bencivenga","year":"2023","journal-title":"Journal of Personalized Medicine"},{"key":"10.1016\/j.bcp.2026.117961_b0625","doi-asserted-by":"crossref","first-page":"22596","DOI":"10.1038\/s41598-024-73062-y","article-title":"Integrated analysis to identify biological features and molecular markers of poorly cohesive gastric carcinoma (PCC)","volume":"14","author":"Liu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117961_b0630","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1471-4159.2002.01200.x","article-title":"Matrix metalloproteinase mediated degradation of basement membrane proteins in Trembler J neuropathy nerves","volume":"83","author":"Misko","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2026.117961_b0635","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41419-024-06656-z","article-title":"GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117961_b0640","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.molcel.2015.09.019","article-title":"USP4 Auto-Deubiquitylation Promotes Homologous Recombination","volume":"60","author":"Wijnhoven","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0645","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.230068","article-title":"RNF4 and USP7 cooperate in ubiquitin-regulated steps of DNA replication","volume":"13","author":"Chang","year":"2023","journal-title":"Open Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0650","doi-asserted-by":"crossref","unstructured":"H.J. Kang, H. Park, E.J. Yoo, J.H. Lee, S.Y. Choi, W. Lee-Kwon, K.Y. Lee, J.H. Hur, J.K. Seo, J.S. Ra, E.A. Lee, K. Myung, H.M. Kwon, TonEBP Regulates PCNA Polyubiquitination in Response to DNA Damage through Interaction with SHPRH and USP1, iScience, 19 (2019) 177-190.","DOI":"10.1016\/j.isci.2019.07.021"},{"key":"10.1016\/j.bcp.2026.117961_b0655","first-page":"1413","article-title":"USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168, Cell cycle (Georgetown","volume":"14","author":"Zhu","year":"2015","journal-title":"Tex.)"},{"key":"10.1016\/j.bcp.2026.117961_b0660","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41467-018-03455-x","article-title":"The H2B deubiquitinase Usp22 promotes antibody class switch recombination by facilitating non-homologous end joining","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117961_b0665","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.celrep.2016.04.041","article-title":"The SAGA Deubiquitination Module Promotes DNA Repair and Class Switch Recombination through ATM and DNAPK-Mediated \u03b3H2AX Formation","volume":"15","author":"Ramachandran","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.117961_b0670","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113462","article-title":"Histone Monoubiquitination in Chromatin Remodelling: Focus on the Histone H2B Interactome and Cancer","volume":"12","author":"Marsh","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.117961_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112990","article-title":"The E3 ubiquitin ligase DTX3L and the deubiquitinase USP28 fine-tune DNA repair through mutual regulation of their protein levels","volume":"28","author":"Mennerich","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.bcp.2026.117961_b0680","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cell.2006.06.039","article-title":"A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response","volume":"126","author":"Zhang","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0685","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tig.2020.12.005","article-title":"Histone Ubiquitination: an Integrative Signaling Platform in Genome Stability, Trends in genetics","volume":"37","author":"Mattiroli","year":"2021","journal-title":"TIG"},{"key":"10.1016\/j.bcp.2026.117961_b0690","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12967-024-06001-0","article-title":"A novel USP4 inhibitor that suppresses colorectal cancer stemness by promoting \u03b2-catenin and Twist1 degradation","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.117961_b0695","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061582","article-title":"The Deubiquitinase USP4 Stabilizes Twist1 Protein to Promote Lung Cancer Cell Stemness","volume":"12","author":"Li","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.117961_b0700","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002446","article-title":"FBXO3 stabilizes USP4 and Twist1 to promote PI3K-mediated breast cancer metastasis","volume":"21","author":"Xu","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0705","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18017","article-title":"USP11 promotes glycolysis by regulating HIF-1\u03b1 stability in hepatocellular carcinoma","volume":"28","author":"Qiao","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2026.117961_b0710","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1002\/ptr.70022","article-title":"Discovery of Baicalein as a Novel Ubiquitin-specific Protease 21 Inhibitor for the Treatment of Hepatocellular Carcinoma","volume":"39","author":"Jia","year":"2025","journal-title":"Phytotherapy Research : PTR"},{"key":"10.1016\/j.bcp.2026.117961_b0715","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41389-021-00338-7","article-title":"USP29-mediated HIF1\u03b1 stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis","volume":"10","author":"Gao","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bcp.2026.117961_b0720","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1016\/j.apsb.2025.07.003","article-title":"USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.117961_b0725","article-title":"USP38 promotes deubiquitination of K11-linked polyubiquitination of HIF1\u03b1 at Lys769 to enhance hypoxia signaling","volume":"300","author":"Wang","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.117961_b0730","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/s41467-023-38605-3","article-title":"ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117961_b0735","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.apsb.2020.11.005","article-title":"Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.117961_b0740","doi-asserted-by":"crossref","first-page":"986","DOI":"10.7150\/thno.117900","article-title":"Single-cell RNA sequence analysis reveals USP32 as a therapeutic target to mitigate PD-L1-driven colorectal tumorigenesis in vitro and in vivo","volume":"16","author":"Birappa","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.117961_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115024","article-title":"Targeting USP47 enhances immunotherapy in hepatocellular carcinoma by destabilizing PD-L1","volume":"161","author":"Jiang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.117961_b0750","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/s41418-023-01219-9","article-title":"USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1","volume":"30","author":"Kuang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.117961_b0755","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1186\/s12967-025-06812-9","article-title":"USP5-Mediated PD-L1 deubiquitination regulates immunotherapy efficacy in melanoma","volume":"23","author":"Xie","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.117961_b0760","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41418-022-01102-z","article-title":"Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer","volume":"30","author":"Yang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.117961_b0765","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15252\/embr.201541392","article-title":"The deubiquitinase Usp27x stabilizes the BH3-only protein Bim and enhances apoptosis","volume":"17","author":"Weber","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcp.2026.117961_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101422","article-title":"Cathepsin K inhibition-induced mitochondrial ROS enhances sensitivity of cancer cells to anti-cancer drugs through USP27x-mediated Bim protein stabilization","volume":"30","author":"Seo","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2026.117961_b0775","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molcel.2007.12.015","article-title":"The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression","volume":"29","author":"Zhang","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0780","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/febs.13290","article-title":"Deubiquitinating enzymes regulate Hes1 stability and neuronal differentiation","volume":"282","author":"Kobayashi","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2026.117961_b0785","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.molcel.2016.03.030","article-title":"ATXN7L3 and ENY2 Coordinate activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth","volume":"62","author":"Atanassov","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0790","article-title":"USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy","volume":"121","author":"Li","year":"2024","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.117961_b0795","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41419-025-07807-6","article-title":"Targeting the TRIM14\/USP14 axis enhances radiotherapy efficacy by inducing GPX4 degradation and disrupting ferroptotic defense in HCC","volume":"16","author":"Yue","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117961_b0800","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41598-025-34903-6","article-title":"LncRNA FOXP4-AS1 facilitates colorectal cancer invasion and migration by enhancing USP7 interaction with ZEB1","volume":"16","author":"Yang","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117961_b0805","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2427415","article-title":"A positive feedback loop of SRSF9\/USP22\/ZEB1 promotes the progression of ovarian cancer","volume":"25","author":"Wang","year":"2024","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0810","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7150\/jca.48056","article-title":"USP43 directly regulates ZEB1 protein, mediating proliferation and metastasis of colorectal cancer","volume":"12","author":"Ye","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.bcp.2026.117961_b0815","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41419-023-05699-y","article-title":"USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma","volume":"14","author":"Zeng","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117961_b0820","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/s41418-021-00754-7","article-title":"Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma","volume":"28","author":"Li","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.117961_b0825","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13046-024-03241-2","article-title":"Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation","volume":"43","author":"Sirera","year":"2024","journal-title":"Journal of Experimental & Clinical Cancer Research : CR"},{"key":"10.1016\/j.bcp.2026.117961_b0830","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4251\/wjgo.v16.i3.1006","article-title":"Ubiquitin-specific protease 21 promotes tumorigenicity and stemness of colorectal cancer by deubiquitinating and stabilizing ZEB1","volume":"16","author":"Lin","year":"2024","journal-title":"World Journal of Gastrointestinal Oncology"},{"key":"10.1016\/j.bcp.2026.117961_b0835","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1158\/1541-7786.MCR-22-0552","article-title":"USP10 Regulates ZEB1 Ubiquitination and Protein Stability to Inhibit ZEB1-Mediated Colorectal Cancer Metastasis","volume":"21","author":"Sun","year":"2023","journal-title":"Molecular Cancer Research : MCR"},{"key":"10.1016\/j.bcp.2026.117961_b0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107722","article-title":"Targeting USP47 enhances the efficacy of KRAS inhibitor in KRAS(G12C) mutated non-small cell lung cancer by controlling deubiquitination of c-Myc","volume":"215","author":"Shin","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.117961_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114917","article-title":"USP7 deubiquitinates KRAS and promotes non-small cell lung cancer","volume":"43","author":"Huang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.117961_b0850","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41419-024-06740-4","article-title":"The role of USP7-YY1 interaction in promoting colorectal cancer growth and metastasis","volume":"15","author":"Shao","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117961_b0855","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-021-01920-y","article-title":"NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer","volume":"40","author":"Li","year":"2021","journal-title":"Journal of Experimental & Clinical Cancer Research : CR"},{"key":"10.1016\/j.bcp.2026.117961_b0860","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.2147\/CMAR.S290467","article-title":"USP5 Promotes Uterine Corpus Endometrial Carcinoma Cell Growth and Migration via mTOR\/4EBP1 Activation","volume":"13","author":"Li","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bcp.2026.117961_b0865","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41420-024-01898-4","article-title":"Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K\/AKT\/HIF-1\u03b1 signal pathway in endometrial carcinoma","volume":"10","author":"Wei","year":"2024","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.bcp.2026.117961_b0870","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/ijms16010307","article-title":"USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition","volume":"16","author":"Ding","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b0875","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41417-023-00718-8","article-title":"USP30 promotes the progression of breast cancer by stabilising Snail","volume":"31","author":"Sun","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0880","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113090","article-title":"USP1 Regulates TAZ Protein Stability through Ubiquitin modifications in Breast Cancer","volume":"12","author":"Mussell","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.117961_b0885","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12964-019-0480-x","article-title":"Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer","volume":"17","author":"Zhang","year":"2019","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2026.117961_b0890","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238949","article-title":"Knocking down USP39 Inhibits the growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway","volume":"21","author":"Yuan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b0895","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7150\/ijbs.87176","article-title":"Ubiquitin-specific Protease 35 Promotes Gastric Cancer Metastasis by increasing the Stability of Snail1","volume":"20","author":"Ma","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153705","article-title":"Deubiquitinase USP13 promotes the epithelial-mesenchymal transition and metastasis in gastric cancer by maintaining Snail protein","volume":"229","author":"Zhang","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bcp.2026.117961_b0905","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41388-022-02267-0","article-title":"USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer","volume":"41","author":"Liu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117961_b0910","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: Emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117961_b0915","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: Biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.117961_b0925","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/0008-5472.CAN-22-0264","article-title":"SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4\/6 Inhibitors","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117961_b0930","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg8876","article-title":"CDK4\/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2026.117961_b0935","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(25)00052-2","article-title":"Gastric cancer","volume":"405","author":"Sundar","year":"2025","journal-title":"Lancet (london, England)"},{"key":"10.1016\/j.bcp.2026.117961_b0940","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","article-title":"Signaling pathways and therapeutic interventions in gastric cancer","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0945","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b0950","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-025-02245-6","article-title":"Traditional chinese medicine in lung cancer treatment","volume":"24","author":"Xi","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.117961_b0955","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cac2.12645","article-title":"Current status and perspectives of esophageal cancer: a comprehensive review","volume":"45","author":"Jiang","year":"2025","journal-title":"Cancer Communications (london, England)"},{"key":"10.1016\/j.bcp.2026.117961_b0960","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.3748\/wjg.v30.i20.2638","article-title":"Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma","volume":"30","author":"Zhao","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2026.117961_b0965","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/0008-5472.CAN-22-2709","article-title":"Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-negative Breast Cancer","volume":"83","author":"Liao","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117961_b0970","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s11671-025-04308-5","article-title":"Advances in nanoparticle-based doxorubicin delivery: precision strategies for targeted treatment of triple-negative breast cancer","volume":"20","author":"Ramayanam","year":"2025","journal-title":"Discover Nano"},{"key":"10.1016\/j.bcp.2026.117961_b0975","article-title":"Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model","volume":"161","author":"Pogorzelska","year":"2023","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.bcp.2026.117961_b0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177948","article-title":"Combination therapy with capsaicin and doxorubicin inhibits TNBC metastasis by targeting TGF-beta thereby increasing survival in a 4T1 transplanted murine model","volume":"1003","author":"Ghosal","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117961_b0985","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2021.03.018","article-title":"Long non-coding RNAs in the doxorubicin resistance of cancer cells","volume":"508","author":"Ashrafizaveh","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.117961_b0990","doi-asserted-by":"crossref","DOI":"10.3390\/cells11203294","article-title":"USP7 Induces Chemoresistance in Triple-negative Breast Cancer via Deubiquitination and Stabilization of ABCB1","volume":"11","author":"Lin","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.117961_b0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b1000","article-title":"5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition","volume":"137","author":"Sethy","year":"2021","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.bcp.2026.117961_b1005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1231401","article-title":"Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies","volume":"14","author":"Cheng","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117961_b1010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41388-019-0999-8","article-title":"Metabolic targeting of HIF-1\u03b1 potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer","volume":"39","author":"Wei","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117961_b1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155647","article-title":"Liensinine sensitizes colorectal cancer cells to oxaliplatin by targeting HIF-1\u03b1 to inhibit autophagy","volume":"129","author":"Feng","year":"2024","journal-title":"Phytomedicine : International Journal of Phytotherapy and Phytopharmacology"},{"key":"10.1016\/j.bcp.2026.117961_b1020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117961_b1025","article-title":"Cisplatin-induced ototoxicity: from signaling network to therapeutic targets","volume":"157","author":"Wang","year":"2023","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.bcp.2026.117961_b1030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10717544.2022.2057617","article-title":"Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3\/SOX2 axis","volume":"29","author":"Xie","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bcp.2026.117961_b1035","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.7150\/thno.51797","article-title":"Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.117961_b1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.116037","article-title":"Study on the mechanism of PSENEN in modulating cisplatin resistance in NSCLC through stromal cell interactions","volume":"169","author":"Cao","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.117961_b1045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168885","article-title":"Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy","volume":"22","author":"Kryczka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b1050","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3892\/mmr.2020.11188","article-title":"Knockdown of ubiquitin\u2011specific protease 51 attenuates cisplatin resistance in lung cancer through ubiquitination of zinc\u2011finger E\u2011box binding homeobox 1","volume":"22","author":"Zhou","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bcp.2026.117961_b1055","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.immuni.2021.04.021","article-title":"Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer","volume":"54","author":"Buechler","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.117961_b1060","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/onc.2013.191","article-title":"Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression","volume":"33","author":"Comito","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117961_b1065","doi-asserted-by":"crossref","unstructured":"R.L. Barrett, E. Pur\u00e9, Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy, eLife, 9 (2020).","DOI":"10.7554\/eLife.57243"},{"key":"10.1016\/j.bcp.2026.117961_b1070","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2147\/IJN.S290438","article-title":"Application of Radiosensitizers in Cancer Radiotherapy","volume":"16","author":"Gong","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2026.117961_b1075","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1038\/s41467-021-24298-z","article-title":"Non-canonical function of DGCR8 in DNA double-strand break repair signaling and tumor radioresistance","volume":"12","author":"Hang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117961_b1080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2014.11.002","article-title":"Deubiquitinase inhibition as a cancer therapeutic strategy","volume":"147","author":"D'Arcy","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b1085","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1021\/jm501061a","article-title":"Inhibiting the deubiquitinating enzymes","volume":"58","author":"Ndubaku","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117961_b1090","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.chembiol.2011.08.018","article-title":"Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes","volume":"18","author":"Altun","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bcp.2026.117961_b1095","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1124\/mol.119.117390","article-title":"The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison","volume":"96","author":"Cowell","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117961_b1100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111706","article-title":"PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the suppression of c-Myc: an In Vitro and In Vivo Study","volume":"22","author":"Hsu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117961_b1105","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12919","article-title":"Inhibition of deubiquitination by PR-619 induces apoptosis and autophagy via ubi-protein aggregation-activated ER stress in oesophageal squamous cell carcinoma","volume":"54","author":"Wang","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bcp.2026.117961_b1110","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/imm.13683","article-title":"Deubiquitinase inhibitor PR-619 potentiates colon cancer immunotherapy by inducing ferroptosis","volume":"170","author":"Wu","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2026.117961_b1115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12967-024-05060-7","article-title":"Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1\u03b1 and PPAR\u03b1-mediated autophagy pathway","volume":"22","author":"Yang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.117961_b1120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2147\/DMSO.S181572","article-title":"Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action","volume":"11","author":"Firouzi","year":"2018","journal-title":"Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy"},{"key":"10.1016\/j.bcp.2026.117961_b1125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/DDDT.S338881","article-title":"Berbamine Suppresses the growth of Gastric Cancer Cells by Inactivating the BRD4\/c-MYC Signaling Pathway","volume":"16","author":"Li","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bcp.2026.117961_b1130","first-page":"24838","article-title":"Berbamine (BBM), a Natural STAT3 Inhibitor","volume":"5","author":"Zhao","year":"2020","journal-title":"Synergistically Enhances the Antigrowth and Proapoptotic Effects of Sorafenib on Hepatocellular Carcinoma Cells, ACS Omega"},{"key":"10.1016\/j.bcp.2026.117961_b1135","doi-asserted-by":"crossref","first-page":"11690","DOI":"10.12998\/wjcc.v10.i32.11690","article-title":"Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment","volume":"10","author":"Huang","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.bcp.2026.117961_b1140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41420-025-02466-0","article-title":"Physiological roles and therapeutic implications of USP6","volume":"11","author":"Syed","year":"2025","journal-title":"Cell Death Discovery"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226002947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226002947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:37:39Z","timestamp":1793943459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226002947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":228,"alternative-id":["S0006295226002947"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117961","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ubiquitin-specific peptidase 51: A potential target in cancer progression and therapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117961"}}